Exploiting the fitness cost of metallo-β-lactamase expression can overcome antibiotic resistance in bacterial pathogens
The study reveals that bacteria expressing metallo-β-lactamases (VIM-2), which are the last-resort antibiotics, have impaired growth in zinc-deprived environments. The researchers identified molecular pathways critical for VIM-2 expression under zinc limitation, revealing that disruption of envelope stress response pathways reduced VIM-2-expressing bacteria’s growth. They also found that VIM-2 expression makes bacteria more susceptible to azithromycin, demonstrating its therapeutic potential against VIM-2-expressing pathogens. This could potentially accelerate the discovery of additional treatments for multidrug-resistant bacteria infections.
AMR NEWS
Your Biweekly Source for Global AMR Insights!
Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.
Don’t miss out on staying ahead in the global AMR movement—subscribe now!